ClinicalTrials.gov
public full text
Public Domain
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK#853685
- BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent#1030212
- Administration of Virus-Specific Cytotoxic T-Lymphocytes#841304
- Ocoxin oral solution demonstrates antiviral properties in cellular models#287864
- Développement de modèles d'infection 2D et 3D du système nerveux central par le virus West Nile et caractérisation de l'activité antivirale de différents composés chimiques#156061
Record · ID 1164794
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive